For example, bioinformatics analyses have shown that certain MMPs, such as MMP-1, MMP-11, MMP-19, and MMP-21, are consistently upregulated in GBM compared to normal brain tissue, suggesting that they may serve as biomarkers for diagnosis and prognosis in high-grade gliomas [91]. This evidence concerns the gene MMP11 and central nervous system cancer.